Objectives. Our aim was to establish whether alcohol protects against RA development and to determine whether this effect is influenced by alcohol dose, duration and serological status through systematically reviewing the literature and undertaking a meta-analysis.
Introduction
Many risk factors have been implicated in the development of RA [1] . Their impact varies according to patients' RF and antibodies to citrullinated protein antigen (ACPA) status [2] . Genetic risk factors have been studied in the most detail with over 30 risk loci established for seropositive RA [3] . Smoking is the main environmental risk factor identified to date, which also predominantly predisposes to seropositive RA [4] . The roles of other environmental risk factors are less clear. The emergence of risk prediction models, which combine geneenvironment factors to identify individuals at a high risk of RA, highlight the importance of accurately defining RA's underlying risk factors [5] .
Recent casecontrol studies show that fewer RA patients drink alcohol when compared with controls; this finding suggests that alcohol intake may protect against the development of RA [6, 7] . As with smoking this relationship is greater for ACPA-positive RA and increases with exposure. This beneficial effect of alcohol, which has attracted substantial media interest, has not been identified in a number of earlier studies [8, 9] . As a consequence its significance is controversial.
We therefore systematically reviewed observational studies evaluating the relationship between alcohol intake and the development of RA and undertook a meta-analysis. Our primary aim was to examine if alcohol affected the risk of RA, through testing the hypothesis that alcohol intake influenced the likelihood of RA development. Our secondary aims were to establish if this relationship varied by serological status and according to the level and duration of alcohol consumed, through testing the hypotheses that alcohol intake predominantly affected seropositive RA risk and that this risk varied according to the level and duration of alcohol intake.
Methods
Reporting structure and data extraction We adopted the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) checklist for the reporting of this review [10] . Our literature search, data extraction and study quality assessments were performed in an independent, unblinded manner by two authors (I.C.S. and R.T.). Discrepancies were resolved by discussion. Inclusion criteria and analytical methods were pre-specified in a protocol.
Search strategy
Medline (from 1946 to July 2012) and EMBASE (from 1947 to July 2012) were searched using the Ovid platform (search last performed July 2012). The search terms comprised: rheumatoid arthritis.mp or arthritis, rheumatoid/ and alcohol.mp or ethanol/. Reference lists of included manuscripts were reviewed for relevant papers. EndNote version X5 (Thomson Reuters, NY, USA) was used for citation management.
Selection criteria
Observational studies were included that: (i) were casecontrol or cohort design; (ii) examined the relationship between alcohol intake and the risk of RA development; and (iii) reported effect size data as odds ratios (ORs) or relative risks (RRs) with 95% CIs or provided data allowing for their calculation.
We excluded: (i) additional studies evaluating the same cohort (only the largest study with the most complete information was included); and (ii) unpublished studies (conference abstracts). All identified abstracts were published in English; we did not identify any studies in non-English languages fulfilling our inclusion criteria from abstract review.
Data extraction
We extracted the following data: author and manuscript names, study design, publication year, sample size, demographics (age and gender), RA characteristics (disease duration, disease activity, serology and radiographic erosions), information on alcohol intake, effect size data (ORs or RRs with 95% CIs), adjustment factors included in the analyses and geographical area.
Assessment of study quality
To evaluate the validity of the included studies their quality was assessed using the NewcastleOttawa Scale (advocated by the Cochrane Non-Randomised Studies Methods Working Group) [11, 12] . This provides points (termed stars) for eight items across three domains comprising group selection (maximum 4 points), comparability of cohorts or cases and controls (maximum 2 points) and ascertainment of outcome of interest or exposure (maximum 3 points). Individual components of each domain are detailed in supplementary Tables S1 and S2 (available as supplementary data at Rheumatology Online). The total score ranges from 0 to 9. Study quality scores have been criticized within the literature because they often incorporate diverse items that are weighted differently [13] ; we have, therefore, provided a breakdown score for each domain subscale in addition to the total summary score.
Statistical analysis
We estimated pooled ORs/RRs and standard errors using a random-effects model based on DerSimonian and Laird's approach [14] . This model was adopted because it considers heterogeneity, which was present between our studies. It assumes that, in addition to the presence of random sampling error, any variability in mean effect size is also due to variation in study populations and procedures (between-study heterogeneity).
Due to the low prevalence of RA, which is estimated to affect 0.81% of the UK adult population [15] , ORs and RRs were used interchangeably [16] . Individual study and overall effect size data were summarized using forest plots. Casecontrol and cohort studies were analysed both separately and together, with pooled ORs/RRs calculated in both instances. For all statistical tests P < 0.05 were considered significant. Data were analysed using the statistical environment R, version 2.14.1 (R Foundation for Statistical Computing, Vienna, Austria), Stata, version 10.1 (Stata Corp., College Station, TX, USA) and MetaP (Dongliang G, Duke Institute For Genome Sciences & Policy, NC, USA) [17] .
Study heterogeneity
Between-study heterogeneity was assessed using Cochran's Q-test and the I 2 -statistic. The latter describes the percentage of total variation across studies due to heterogeneity rather than chance. It ranges from 0% (no heterogeneity) to 100% (high heterogeneity) with I 2 -values of 25, 50 and 75% having tentatively been suggested to represent low, moderate and high heterogeneity, respectively [18] . Meta-regression was undertaken to evaluate study publication year and quality as potential sources of heterogeneity between studies [19] . Within-study heterogeneity (differences between cases and controls) was evaluated descriptively.
Primary outcome analysis
Our primary outcome measure was the OR of developing RA in drinkers vs non-drinkers. Where possible we combined OR/RRs that had adjusted for confounding variables such as age, gender and smoking. In studies only reporting adjusted risks stratified by alcohol intake we combined the different alcohol intake groups into one common OR/RR to estimate the risk of RA for all drinkers using an inverse variance fixed-effects model [19] . In studies not reporting adjusted risks, unadjusted risks were used (calculated from crude data). Due to heterogeneity in the reporting of alcohol intake and RA risk we used the following categories to represent no alcohol in three studies: 01 U/week [9] , <1 or never glasses of alcohol/ week [20] and self-classification as a never-regular drinker [6] . The latter was used because adjusted risks were only reported for never-vs ever-regular drinkers and this study had significant differences between cases and controls for age, gender and smoking status, which meant that unadjusted risks for drinkers vs non-drinkers calculated from crude data could be affected by confounding.
Subgroup analysis
We undertook three subgroup analyses evaluating: (i) risk differences between ACPA/RF-positive and ACPA/RF-negative RA; (ii) the impact of alcohol quantity on RA risk; and (iii) the impact of drinking duration on RA risk.
Due to variation between studies in the categories of alcohol intake used to report risk it was not possible to combine them to give a summary OR for each drinking category. We therefore examined doserisk relationships within studies using trend tests. Where these were not reported the CochranArmitage test for trend was calculated using crude data [21] . We also combined trend test P-values from each study using Stouffer's Z trend test [22] . Levels of alcohol intake were broadly grouped into three categories-low, moderate and high-according to individual study classifications. In studies using low alcohol intake as the reference group, ORs/RRs were recalculated using crude data and taking no alcohol as the reference group. Because only two studies evaluated alcohol intake on more than one occasion (both reporting risk differently) the impact of drinking duration on RA was evaluated descriptively.
Publication bias and selection bias
Publication bias was looked for by constructing funnel plots and applying Begg and Mazumudar's [23] adjusted rank correlation method and Sterne and Egger's [24] linear regression approach.
Examining the influence of individual studies
We repeated our analyses excluding one study at a time. This allowed us to investigate the influence of individual studies on the meta-analysis summary OR and ensure our findings were not attributable to a single study with a large effect size [25] .
Results

Studies identified
We screened 893 articles, identifying 22 potential manuscripts from their title or abstract (Fig. 1 ). Fourteen were excluded: three evaluated the same cohort [2, 26, 27] ; two evaluated other risk factors [28, 29] ; five examined other issues [30] [31] [32] [33] [34] ; three were not observational studies (two letters [35, 36] and one review [37] ); one did not report effect size data or provide data for its calculation [38] . Additionally the latter study used a self-reported diagnosis of RA that increased the likelihood of case misclassification (reflected in its high reported RA prevalence figures of 5% in men and 7% in women). We therefore did not attempt to contact its authors to obtain raw data for effect size calculation. Eight articles were included, which reported nine separate studies (Table 1) . Three were cohort and six were casecontrol designs.
Cohort studies
The minimum, maximum and median values for the cohort study sizes comprised 18 944; 34 141 and 31 336, respectively. The same values for the ages of included individuals comprised 45, 62 and 61 years, respectively. Two studies examined only females; in the other gender was not described. Two reported serology: one restricted analysis to RF-positive RA; in the other 61% of cases were RF positive. Follow-up periods were 7 [20] , 11 [39] and 16 years [40] .
Casecontrol studies
As summary statistics for the casecontrol studies, we present the minimum, maximum and median number of cases evaluated by each study (135; 1204 and 501.5), the number of controls evaluated (378; 4234 and 937.5), the ages of included cases (49, 61 and 51 years) and the ages of included controls (48, 52 and 50 years). Most studies examined females: three studies evaluated only females; in the remainder 70% were women. One study recruited controls from the same hospital clinic as cases [41] ; the remainder recruited population-based controls. Three studies reported disease duration: two evaluated early (42 years) [7] and one established (mean duration 14 years) RA [6] . Four studies reported serology, with seropositive cases ranging from 50 to 79%. Only one reported data on erosions and disease activity: all patients had erosive RA and most moderate disease activity [6] .
Alcohol intake definitions and assessment
There was marked variation in the definition of alcohol intake between studies (Table 1) , which defined alcohol consumption on a daily, weekly, monthly or lifetime basis and in units, number of drinks or grams of alcohol.
There was further heterogeneity between studies regarding alcohol intake assessment methods. Five used questionnaires [6, 7, 20, 39, 40] , three interviews [7, 8, 41] and one medical record review [9] . Alcohol intake was also evaluated at different time points prior to or at RA onset: two cohort studies recorded intake at cohort baseline [39, 40] , one study recorded intake 10 years previously [7] , two recorded current intake alongside habitual consumption [6, 7] , one recorded intake at initial presentation [41] , one recorded intake at an unspecified time point [9] and two evaluated intake at multiple time points [8, 20] .
Study quality
Study quality scores are shown in Table 1 . One study had a NewcastleOttawa Score of 6, seven scored 7 and one scored 8. Some cohort studies were not allocated points because they used questionnaires to evaluate drinking; additionally one study failed to adjust for smoking [39] and another had a relatively short follow-up period of 7 years [20] . Some casecontrol studies were not allocated points because they captured information on alcohol intake from unblinded interviews or questionnaires, did not fully report response rates or had differing response rates between cases and controls.
Although a proportion of studies had differences between cases and controls with regards to age, gender and smoking, they did not lose points for comparability as they adjusted for these factors in their analysis.
Alcohol intake and the overall risk of RA
All studies
All nine studies evaluated alcohol intake and the risk of RA (Table 2 ; Fig. 2a ). Alcohol drinkers were less likely to develop RA, with a significant risk reduction in drinkers vs non-drinkers (OR 0.78; 95% CI 0.63, 0.96).
Cohort studies
When restricting our meta-analysis to cohort studies, a non-significant inverse relationship was observed-the OR for RA in drinkers vs non-drinkers was 0.91 (95% CI 0.78, 1.07).
Casecontrol studies
When restricting our meta-analysis to casecontrol studies a more significant inverse relationship was seen-the OR for RA in drinkers vs non-drinkers was 0.70 (95% CI 0.51, 0.95). Alcohol intake and the risk of ACPA-positive and ACPA-negative RA Three casecontrol studies evaluated the impact of alcohol intake on the risk of ACPA-positive and ACPAnegative RA ( [40] .
Doserisk relationship between alcohol and RA
This was evaluable in all nine studies (Table 2) . Four reported a significant inverse doserisk relationship between alcohol intake and RA development. The remainder showed no relationship. Combining trend tests across studies provided an estimated summary P-value of 0.09; there was therefore no overall significant doserisk relationship present.
Impact of alcohol intake duration on RA risk
One cohort study evaluated intake at two time points a decade apart, finding that those consuming more than three glasses of alcohol per week sustained over this period were at a lower risk of RA compared with those with less prolonged drinking [20] . One casecontrol study evaluated average lifetime alcohol intake; no impact on RA risk was observed [8] .
Individual study influences
Excluding individual studies from our meta-analysis did not radically alter the summary OR for RA (Table 3) . Our findings were therefore not solely attributable to a single study. Excluding three casecontrol studies resulted in a borderline significant OR (upper 95% CI 1.00).
Study heterogeneity
There was significant heterogeneity between studies examining the overall risk of RA (P < 0.0001; I 2 = 80.3%) and ACPA-positive RA (P = 0.019; I 2 = 74.8%) but not those evaluating ACPA-negative RA (P = 0.16; I 2 = 44.7%).
There was no evidence that study publication year (P = 1.00) influenced RA risk when evaluated by metaregression (although the small number of included studies meant this technique had limited power). The impact of study quality was significant (P = 0.03), with increasing quality associated with a reduced protective effect of alcohol. This is attributable to the lower score ascribed to Maxwell et al. [6] and the higher score ascribed to Heliö vaara et al. [40] , but is difficult to interpret given the score's limited variability.
Three studies reported differences between cases and controls in age and gender: one study had younger controls (average difference 13 years) [6] and two studies had more female cases [6, 7] . Five studies reported differences in smoking status: in four studies smoking rates were higher in cases [6, 7, 9] and in one study smoking rates were higher in controls [41] . Most studies adjusted for these potentially confounding variables-comprising age, gender and smoking-in multivariate analyses.
Publication bias
There was some evidence of funnel plot asymmetry (Fig. 3) , which displays two lower precision studies with large effect sizes favouring a protective effect of alcohol against RA and an absence of similarly lower precision studies of effect sizes in the opposing direction.
Although this suggests publication bias may be present, such bias was not detected by Begg's rank correlation (P = 0.25) or Egger's weighted regression methods (P = 0.22). Additionally the small number of included studies means that publication bias is difficult to assess [25] .
Discussion
Our systematic review provides evidence of an inverse relationship between the presence of RA and the consumption of alcohol at or prior to disease onset. It shows that this relationship is predominantly confined to ACPA-positive RA, with a non-significant association observed for ACPA-negative RA. Although these findings suggest that alcohol protects against ACPA-positive RA and support the concept that environmental risk factors differ between RA subsets defined by ACPA status, caution is required in their interpretation as this significant relationship is confined to casecontrol studies, which have marked heterogeneity between them. The discrepancy in risk according to ACPA status is interesting. These two subsets are known to differ phenotypically with ACPA-positive RA having lower remission rates and more radiographic erosions [42, 43] . Their underlying genetic and environmental risk factors also appear to differ, which is a concept mirrored by our review. A recent genome-wide association study has indicated distinct genetic architectures with risk allele frequency differences between subsets [44] . A large casecontrol study has identified divergent environmental risks with ACPA-positive RA linked with smoking, alcohol and oral contraceptive pill use and ACPA-negative RA linked with obesity [2] . There is therefore growing evidence that these subsets have different pathophysiologies and may be considered distinct disease entities [45] . Our review supports this perspective. Due to a lack of data it was not possible to establish if similar environmental risk differences existed for RF-positive and RF-negative RA, although evidence from a smoking meta-analysis suggests these may be present [4] .
One potential mechanism through which alcohol could protect against the development of RA is via attenuation of the innate inflammatory response. In experimental animal models, alcohol inhibited the onset of a collageninduced inflammatory arthritis through down-regulating leucocyte migration, up-regulating testosterone secretion and reducing nuclear factor-kB (NF-kB) activation [46] . Alcohol has also been shown to have anti-inflammatory effects in humans through similar mechanisms such as reducing NF-kB-driven inflammatory mediator production by monocytes [47] (a key cellular pathway in RA [48] ). An alternative explanation for this inverse relationship is that individuals with lowmoderate alcohol intake have healthier lifestyles compared with complete abstainers who may do so for reasons such as chronic illness; RA could therefore result from confounding lifestyle factors. This explanation has been proposed to explain the J-shaped relationship that exists between drinking alcohol and overall mortality and cardiovascular disease [49] .
It would have been of interest to establish if the effects of alcohol on RA risk differ by gender. This is present with smoking, with substantially higher ORs for RA seen in male compared with female smokers [4] . Due to a lack of data we could not establish this for alcohol although the single study that subdivided risk between sexes found similar protective effects in both males and females [6] . Additionally we could not systematically examine the combined effect of smoking and alcohol on RA risk, which was only reported in two studies. These did, however, indicate a likely environmentenvironment interaction with a greater alcohol-related risk reduction for ACPA-positive RA observed in ever-smokers compared with never-smokers [7] . The importance of adjusting risk for smoking was highlighted by Di Giuseppe et al. [20] , who found that while drinking was commoner in RA cases because smoking was more prevalent in drinkers the smoking adjusted risk for RA was reduced in those who drank. We consider that as most studies adjusted for smoking status in their analyses, the beneficial effects of alcohol on RA risk were not confounded by smoking.
Our review has several important limitations. Firstly, an overall significant relationship between alcohol and RA was observed in casecontrol but not cohort studies. Casecontrol studies are subject to recall bias, which in this context is a distinct possibility. Numerous reasons exist for individuals with RA to consume less alcohol (such as DMARD use), and therefore asking them to   FIG. 3 Funnel plot of the included studies.
recall past drinking behaviour could be influenced by their current low intake post-diagnosis. Only one casecontrol study evaluated alcohol intake prior to RA onset; the remainder captured information on alcohol intake at RA development or prior to it through retrospective questionnaires or interviews with no independent means of validating their data. These studies were thus all subject to recall bias. Secondly, due to reporting adjusted risks with low alcohol intake as a reference group, unadjusted risks were used for two studies in the ACPA sub-group analysis [7] . There was, however, little difference between unadjusted and adjusted risks (supplementary Table S3 , available as supplementary data at Rheumatology Online); we therefore consider that the observed relationship is unlikely to be due to confounding variables. Thirdly, we used self-classification as a never-regular drinker to represent no alcohol intake in one study. Although this is not the same as absolute abstinence the numbers of never-regular drinkers were very similar to those reporting no alcohol intake; this therefore represented an appropriate surrogate measure. Finally, there was significant clinical and methodological heterogeneity between the studies, with important differences existing in how they defined and captured alcohol intake; such heterogeneity limits their suitability to be combined within a meta-analysis.
Further research is needed to establish whether alcohol truly protects against the development of RA. One possible explanation for the lack of an overall association observed in the cohort studies was their failure to evaluate RA cases by ACPA status. Ideally, a large prospective cohort study is required, which subdivides incident cases of RA by the presence or absence of ACPA and captures detailed information on disease risk factors and outcomes. Such an approach could provide crucial insight into many RA risk factors in addition to alcohol. This would enable the development of accurate prediction models combining clinical and genetic risk factors to identify individuals at risk of RA. The end result would be the implementation of evidence-based preventative strategies to halt RA development [50] .
Rheumatology key messages
. Casecontrol studies suggest drinking alcohol may be associated with a reduced risk of RA. . Alcohol is mainly associated with ACPA-positive RA implying that environmental risks differ by ACPA status. . Research is required using cohort studies subdividing RA cases by ACPA to determine causality.
